Table 2 Clinical characteristics of the study participants
Characteristic | Case group (n = 63) | Control group (n = 63) | P value |
|---|---|---|---|
Age | 52.86 ± 8.56 | 51.59 ± 7.81 | 0.386 |
Height (cm) | 157.78 ± 4.23 | 158.29 ± 4.17 | 0.499 |
Weight (kg) | 58.25 ± 4.78 | 57.37 ± 5.86 | 0.352 |
Body mass index (kg/m2) | 23.39 ± 1.67 | 22.85 ± 1.74 | 0.078 |
Comorbid diabetes mellitus | 0.219 | ||
Yes | 19 (30.2%) | 13 (20.6%) | |
No | 44 (69.8%) | 50 (79.4%) | |
FIGO Stage | 0.859 | ||
I | 32 (50.8%) | 31 (49.2%) | |
II | 31 (49.2%) | 32 (50.8%) | |
Histologic type | 0.338 | ||
Squamous cell carcinoma | 45 (71.4%) | 38 (60.3%) | |
Adenocarcinoma | 12 (19.0%) | 19 (30.2%) | |
Other | 6 (9.5%) | 6 (9.5%) | |
Number of NACT cycles | 0.021* | ||
0 | 26 (41.3%) | 37 (58.7%) | |
1 | 12 (19.0%) | 13 (20.6%) | |
2 | 25 (39.7%) | 13 (20.6%) | |
Neoadjuvant radiotherapy | 0.051 | ||
Yes | 37 (58.7%) | 26 (41.3%) | |
No | 26 (41.3%) | 37 (58.7%) | |
Surgical method | 0.672 | ||
Laparoscopy | 24 (38.1%) | 22 (34.9%) | |
Laparotomy | 39 (61.9%) | 41 (65.1%) | |
Duration of surgery (h) | 3.2 ± 1.0 | 2.9 ± 0.9 | 0.983 |
Intraoperative bleeding volume (mL) | 253 ± 75 | 256 ± 71 | 0.770 |
Number of lymph nodes resected | 37 ± 7 | 34 ± 8 | 0.008* |
Lymph node metastasis | 0.052 | ||
Yes | 6 (9.5%) | 1 (1.6%) | |
No | 57 (90.5%) | 62 (98.4%) | |
Postoperative pelvic infection | 0.045* | ||
Yes | 22 (34.9%) | 12 (19.0%) | |
No | 41 (65.1%) | 51 (81.0%) | |
Preoperative hemoglobin level (g/L) | 137.08 ± 4.15 | 136.52 ± 5.16 | 0.506 |
Preoperative albumin level (g/L) | 39.68 ± 4.15 | 38.10 ± 5.16 | 0.000* |
Postoperative hemoglobin level (g/L) | 97.44 ± 8.44 | 101.40 ± 8.56 | 0.010* |
Postoperative albumin level (g/L) | 30.39 ± 2.14 | 31.40 ± 2.83 | 0.025* |
Decrease in hemoglobin level (g/L)§ | 39.63 ± 8.83 | 35.13 ± 7.44 | 0.002* |
Decrease in albumin level (g/L)§ | 9.29 ± 2.15 | 6.70 ± 2.34 | 0.000* |